Wang Li-Xiang, Deng Ying-Ping
Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
Int J Ophthalmol. 2021 Jun 18;14(6):915-922. doi: 10.18240/ijo.2021.06.18. eCollection 2021.
Meibomian gland, the largest sebaceous gland of the body, is responsible for the biosynthesis of lipid layer of the tear film to prevent excessive evaporation. The loss of normal functions of meibomian gland, known as meibomian gland dysfunction (MGD), is a chronic disease and is the leading cause of dry eye symptoms in the clinics. Studies have found sex hormones, especially androgen, play vital roles in the regulation of the functions of meibomian gland. Recently, androgen has also been preliminarily applied in clinics for the treatment of MGD and showed promising results, especially in people with endogenous androgen deficiency. This review summarized the mechanisms of the function of androgen on meibomian gland based on molecular, animal, and clinical studies, and proposed evidence-based views about its potential applications for the treatment of MGD.
睑板腺是人体最大的皮脂腺,负责泪膜脂质层的生物合成,以防止过度蒸发。睑板腺正常功能的丧失,即睑板腺功能障碍(MGD),是一种慢性疾病,也是临床上干眼症症状的主要原因。研究发现性激素,尤其是雄激素,在睑板腺功能调节中起着至关重要的作用。最近,雄激素也已初步应用于临床治疗MGD,并显示出有前景的结果,尤其是在内源性雄激素缺乏的人群中。本文综述了基于分子、动物和临床研究的雄激素对睑板腺功能的作用机制,并提出了关于其治疗MGD潜在应用的循证观点。